Immuvac (MIP)

Phase of Development

Phase 3

Vaccine Platform

Mycobacterial – Inactivated

Candidate Overview

Sponsor / Lead Developer: Indian Council of Medical Research

Development partner(s): Cadila Pharmaceuticals

Clinical Trial Status: Active Trials

Primary Indication: Prevention of TB disease

Target Population(s): Adolescents and Adults

Clinical Trials

Registry NumberCTRI/2019/01/017026
Clinical Trial PhasePhase 3
Clinical Trial SponsorIndian Council of Medical Research (ICMR)
Primary endpoint(s) for this clinical trialPrevention of active TB disease
Target population(s) for clinical trialAdults